ALKBH5 regulates the composition of tumor-infiltrating Tregs and MDSCs by affecting Mct4/Slc16a3 expression in TME, ultimately achieving enhanced immunosuppressive effects and promoting melanoma escape. Here, SLC16A3 is linked to melanoma.